3 news items
Bio-Path Holdings Reports First Quarter 2024 Financial Results
BPTH
15 May 24
expenses payable by Bio-Path. Bio-Path intends to use the net proceeds from the offering for working capital and general corporate purposes. In addition
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BPTH
19 Apr 24
for working capital and general corporate purposes. The shares of common stock offered in the registered direct offering
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BPTH
18 Apr 24
expenses payable by Bio-Path. Bio-Path currently intends to use the net proceeds from the offering for working capital and general corporate purposes
- Prev
- 1
- Next